TopFunds

Quest Diagnostics

NYSE: DGX

Stock price

210.68 USD

(+Infinity%) NaN day

Health Care ServicesMedical - Diagnostics & Research

Financial Performance

Share

5Y price score: 78

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 181.2%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    165.3

    52-week range

    219.2

    210.68

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    5.6 %

    Dividend Yield TTM

    1.6 %

    Market cap $

    $ 23,321

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    23.3

    Price / Book TTM

    3.1

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    1.7

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    27.1 %

    67 %

    181.2 %

    Free cash flow per share growth

    49.5 %

    3.1 %

    218.8 %

    Earnings per share growth

    13.8 %

    (16.8) %

    79.7 %

    Founded: 1,967

    Employees: 55,000

    Business Summary:Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Quest Diagnostics — Financial Overview, Stock Price, Market Cap

    Quest Diagnostics is a company. Founded in 1967. As of July 20, 2026, the company's market capitalization is $23321433280 with a current stock price of $210.68.